A Randomized, Triple-blind, Placebo-controlled Study to Evaluate the Effects of a Supplement on Nutrient Gaps and Gut Health Among Individuals Utilizing GLP-1 RAs
NA
This study is a triple-blind, placebo-controlled, randomized controlled tri...
Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period
PHASE3
Primary Objective:
To demonstrate the superiority of the insulin glargine/...
Impact of GLP-1 Receptor Agonists on Dry Eye Disease in Patients With Type 2 Diabetes Mellitus and Obesity
N/A
Diabetes mellitus (DM), prediabetes, and obesity are emerging as major glob...
Status
Recruiting
Location
2nd Department of Internal Medicine, Research Institute and Diabetes Center, National and Kapodistrian University of Athens, Athens, GRC.
Start Date
2026-03-01
Trial ID
NCT07605572
This Randomized Trial Aims to Investigate the Efficacy of Balanced Nutritional Tablets-Comprehensive Multivitamin and Mineral Supplements- in Preventing Micronutrient Deficiencies Among Patients Utilizing GLP-1 RAs for Weight Loss in Comparison to a Placebo Control
PHASE4
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), including Ozempic (s...
Status
Recruiting
Location
Facility Name: The surgical department of Medical Research Institute Hospital, Alexandria University, Alexandria, Facility